Related Experiment Videos
Stereotactic interstitial brachytherapy--current concepts and concerns in twenty patients
Applied Neurophysiology
|January 1, 1985
Summary
Interstitial brachytherapy (IBT) shows promise for malignant brain tumors, potentially increasing survival. Further research is needed to optimize its use regarding tumor type, dosage, and treatment timing.
Area of Science:
- Neurosurgery
- Radiation Oncology
- Medical Imaging
Background:
- Interstitial brachytherapy (IBT) is increasingly used for brain tumors due to advances in imaging and stereotactic techniques.
- IBT, alone or with teletherapy, may improve survival times for patients with malignant brain tumors.
Purpose of the Study:
- To report preliminary results of CT-guided stereotactic IBT in 20 patients with malignant brain tumors.
- To highlight ongoing concerns regarding optimal application of IBT for brain tumors.
Main Methods:
- CT stereotactic interstitial brachytherapy (IBT).
- Inclusion of 20 patients diagnosed with malignant brain tumors.
Main Results:
- Preliminary data from 20 patients undergoing CT stereotactic IBT for malignant brain tumors were analyzed.
- Evidence supports IBT efficacy, but optimal parameters require further investigation.
Conclusions:
- Despite demonstrated efficacy, optimal grade neoplasm, target, dose, and timing for IBT remain areas of concern.
- Current IBT use should be restricted to specialized centers investigating its risks and benefits.